Sclerosants for Variceal Sclerotherapy: A Critical Appraisal

Sarin, S. K.; Kumar, A.
June 1990
American Journal of Gastroenterology;Jun1990, Vol. 85 Issue 6, p641
Academic Journal
Endoscopic sclerotherapy is a well-accepted technique for the treatment of variceal bleeding. It is carried out by injecting a sclerosant into or around a varix. Sclerosants are oily or aqueous chemicals which produce sclerosis, depending on their necroinflammatory and thrombotic properties. The safety and efficacy of various sclerosants bas been evaluated in experimental and human studies. However, due to the presence of a large number of variables, conflicting results have been reported. Based primarily on anecdotal experiences, sodium tetradecyl sulfate, ethanolamine oleate, polidocanol, and alcohol appear to be potent and safe sclerosants. There is great need to perform double-blind trials to identify ideal sclerosant(s) with optimum thrombogenic and minimum necroinflammatory properties.


Related Articles

  • Mesenteric Venous Thrombosis as a Possible Complication of Endoscopic Sclerotherapy: A Report of Two Cases. Thatcher, Bryan S.; Sivak Jr., Michael V.; Ferguson, D. Roy; Petras, Robert E. // American Journal of Gastroenterology;Feb1986, Vol. 81 Issue 2, p126 

    Two cases of mesenteric venous thrombosis with bowel infarction occurring after endoscopic sclerotherapy are reported. In neither patient was the diagnosis suspected or recognized until the terminal phase of the illness. Clinicians should be aware of this possible association and complication of...

  • ACUTE PORTAL VEIN THROMBOSIS, SCLEROTHERAPY, AND VASOPRESSIN: RELATIONSHIPS AND IMPLICATIONS. Snady, Harry // American Journal of Gastroenterology;Dec1987, Vol. 82 Issue 12, p1292 

    Stresses the importance of case reports on three cirrhotics in whom acute portal vein thrombosis (PVT) occurred in apparent close temporal relationship to various treatments, including transfusion, vasopressin and sclerotherapy, given for an episode of variceal bleeding. Factors that cause PVT;...

  • Protrombin 20210 G/A ye MTHFR C677T mutasyonları nedenlyle süperior mezenterik ven trombozu: Olgu sunumu. Yirmibeşoğlu, Müge; Vitoja, Sidita; Çalık, Esat; Terzi, Cem // Turkish Journal of Surgery / Ulusal Cerrahi Dergisi;2011, Vol. 27 Issue 2, p111 

    Aim: To discuss the diagnosis and treatment of superior vein thrombosis in a patient who has hereditary thrombophilia, to point out the importance of preventive treatment in these patients. Materials and Methods: We investigated the whole peroperative period in a patient who underwent emergency...

  • Interventional endoscopic treatment of upper gastrointestinal bleeding – when, how, and how often. Seewald, S.; Seitz, U.; Thonke, F.; Sriram, P. V. J.; He, X. K.; Soehendra, N. // Langenbeck's Archives of Surgery;Apr2001, Vol. 386 Issue 2, p88 

    Acute upper gastrointestinal (GI) bleeding is still associated with high mortality. Reducing the rebleeding rate is the major challenge in therapeutic endoscopy. The following article describes the indications, techniques and limitations of endoscopic treatment of upper GI bleeding. Endoscopic...

  • Esophagus.  // Current Medical Literature: Gastroenterology;2004, Vol. 23 Issue 3, p58 

    Comments on the article "Dieulafoy's lesion of the esophagus correctly diagnosed and successfully treated by the endoscopic injection of N-butyl-2-cyanoarylate," by Yoshida T. Adachi and colleagues, published in the 2004 issue of the periodical "Endoscopy". Potential diagnosis when the bleeding...

  • Endoscopic management of non-variceal upper gastrointestinal bleeding. Yadav, Praveen Kumar; Liu, Zhan-Ju // HealthMed;2012, Vol. 6 Issue 10, p3519 

    No abstract available.

  • Usefulness of a Diluted Prothrombin Time for Accurately Diagnosing Antiphospholipid Syndrome. Nakai, Keiji; Wada, Hideo; Nakatani, Kaname; Kamikura, Yuko; Mastumoto, Takeshi; Kobayashi, Toshihiko; Tonomura, Harue; Tono, Yasutaka; Ohyabu, Mariko; Ota, Satoshi; Yamada, Norikazu; Besho, Yuri; Yamada, Eri; Ikejiri, Makoto; Abe, Yasunori; Nobori, Tsutomu // Vascular Disease Prevention;Jan2009, Vol. 6 Issue 1, p25 

    No abstract available.

  • Mutation in the Prothrombin Gene G20210A as a Cause of Cerebral Venous Thrombosis. Arroyave, Jorge A.; Quinones, Jairo // Case Reports in Medicine;2012, p1 

    Introduction. Cerebral venous sinus thrombosis (CVST) is a rare form of cerebrovascular disease, which may manifest clinically by a wide variety of signs and symptoms. It has been associated with multiple risk factors including genetic or acquired blood disorders, infections, and trauma. Case...

  • Thrombosis from a Prothrombin Mutation Conveying Antithrombin Resistance. Miyawaki, Yuhri; Suzuki, Atsuo; Fujita, Junko; Maki, Asuka; Okuyama, Eriko; Murata, Moe; Takagi, Akira; Murate, Takashi; Kunishima, Shinji; Sakai, Michio; Okamoto, Kohji; Matsushita, Tadashi; Naoe, Tomoki; Saito, Hidehiko; Kojima, Tetsuhito // New England Journal of Medicine;6/21/2012, Vol. 366 Issue 25, p2390 

    : We identified a novel mechanism of hereditary thrombosis associated with antithrombin resistance, with a substitution of arginine for leucine at position 596 (p.Arg596Leu) in the gene encoding prothrombin (called prothrombin Yukuhashi). The mutant prothrombin had moderately lower activity than...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics